Researchers have used a non-invasive method of observing how the process leading to Parkinson's disease takes place at the nanoscale, and identified the point in the process at which proteins in the brain become toxic, eventually ...
Mar 14, 2016
0
256
(HealthDay)—Further investigation of the addition of amphotericin B to Optisol-GS, the most commonly used corneal storage medium in the United States, is warranted, according to research published online Feb. 25 in JAMA ...
Feb 29, 2016
0
2
Guilt-free sugary treats may be on the horizon. Scientists at the University of Montreal Hospital Research Centre (CRCHUM) have discovered an enzyme that can stop the toxic effects of sugar in various organs of the body. ...
Jan 11, 2016
2
165
Electronic cigarettes produce highly-reactive free radicals—molecules associated with cell damage and cancer—and may pose a health risk to users, according to researchers at Penn State College of Medicine.
Dec 3, 2015
1
27
(HealthDay)—Naturally occurring monoclonal antibodies show potential for treatment of neurologic diseases, according to a review published online Sept. 21 in JAMA Neurology.
Sep 22, 2015
0
10
JAMA Oncology will publish two studies, a commentary and an author audio interview examining outcomes in women with breast cancer who had breast-conserving surgery and were treated with hypofractionated radiation therapy ...
Aug 6, 2015
0
15
Patients who relapse in their battle with acute myeloid leukemia (AML) may benefit from a phase three study of therapies that combine an existing agent, cytarabine, with a newer compound, vosaroxin.
Dec 7, 2014
0
1
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Oct 13, 2014
2
0
The increased risk of kidney injury related to the use of hydroxyethyl starch (HES) in resuscitation fluids reflects the mass of HES molecules, according to a report in Anesthesia & Analgesia, official journal of the International ...
Jul 11, 2014
0
0
Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA.
Jul 1, 2014
0
0
